α-Hederin通过触发铁亡并通过PI3K/AKT信号来破坏线粒体功能来抑制骨肉瘤的进展
Baichuan Zhang1, Xianwen Yu1, Yu Yan1
1Department of Emergency, ChongQing General Hospital, Chongqing, China.
Xenobiotica; the fate of foreign compounds in biological systems
|December 4, 2025
概括
α-Hederin通过诱导依赖铁的细胞死亡 (ferroptosis) 和损害线粒体功能,显示出对骨肉瘤的承诺,为这种骨癌提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓瘤是一种流行青少年骨癌,结果不佳.
- 铁和线粒体功能障碍是癌症治疗中的新兴治疗点.
研究的目的:
- 为了研究α-hederin的抗骨肉瘤作用和机制.
- 探索α-hederin在骨髓瘤细胞中的铁和线粒体功能中的作用.
主要方法:
- 综合网络药理学和分子对接以识别目标.
- 在143B骨髓瘤细胞上进行了体外实验.
- 使用传输电子显微镜和西方抹杀用于机械验证.
主要成果:
- α-hederin抑制了骨髓瘤细胞的增殖和迁移.
- 通过增加细胞内铁和脂质过氧化,诱导铁.
- 破坏了线粒体功能,并抑制了PI3K/AKT通路.
- 影响被铁灭抑制剂部分逆转.
结论:
- α-hederin通过诱导铁亡和线粒体功能障碍,在骨髓瘤中表现出抗瘤活性.
- 抑制PI3K/AKT通路有助于α-海德林的作用.
- α-hederin代表了骨髓瘤的潜在治疗剂.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K


